A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fangusaro, JR; Onar-Thomas, A; Young-Poussaint, T; Wu, S; Ligon, AH; Lindeman, NI; Banerjee, A; Packer, R; Kilburn, LB; Pollack, I; Jakacki, R; Qaddoumi, IA; Fisher, PG; Dhall, G; Baxter, PA; Kreissman, SG; Doyle, LA; Smith, MA; Dunkel, IJ; Fouladi, M

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 10504 - 10504

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.10504